ＪＣＲファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/07/21 | 1,250 | 1,257.5 | 1,234 | 1,255 | +5 | +0.4% | 293,700 |
| 2023/07/20 | 1,246 | 1,254.5 | 1,229.5 | 1,250 | +4 | +0.3% | 399,200 |
| 2023/07/19 | 1,247.5 | 1,259 | 1,237 | 1,246 | +2.5 | +0.2% | 382,100 |
| 2023/07/18 | 1,253 | 1,255.5 | 1,231 | 1,243.5 | -6 | -0.5% | 417,800 |
| 2023/07/14 | 1,260 | 1,266.5 | 1,237 | 1,249.5 | -7 | -0.6% | 313,200 |
| 2023/07/13 | 1,234.5 | 1,259 | 1,233.5 | 1,256.5 | +26.5 | +2.2% | 345,700 |
| 2023/07/12 | 1,203 | 1,236 | 1,194 | 1,230 | +29 | +2.4% | 350,000 |
| 2023/07/11 | 1,222.5 | 1,222.5 | 1,198 | 1,201 | -20.5 | -1.7% | 268,700 |
| 2023/07/10 | 1,234 | 1,238 | 1,209.5 | 1,221.5 | -10.5 | -0.9% | 332,300 |
| 2023/07/07 | 1,224 | 1,244 | 1,214.5 | 1,232 | -2 | -0.2% | 319,400 |
| 2023/07/06 | 1,244 | 1,250.5 | 1,228 | 1,234 | -49.5 | -3.9% | 365,400 |
| 2023/07/05 | 1,251.5 | 1,286 | 1,250 | 1,283.5 | +16.5 | +1.3% | 259,400 |
| 2023/07/04 | 1,242 | 1,272.5 | 1,230 | 1,267 | +4 | +0.3% | 471,700 |
| 2023/07/03 | 1,278 | 1,282 | 1,262.5 | 1,263 | -6 | -0.5% | 424,800 |
| 2023/06/30 | 1,305 | 1,305 | 1,262.5 | 1,269 | -43.5 | -3.3% | 456,000 |
| 2023/06/29 | 1,312 | 1,322.5 | 1,301 | 1,312.5 | +11.5 | +0.9% | 480,400 |
| 2023/06/28 | 1,262.5 | 1,301.5 | 1,252 | 1,301 | +45.5 | +3.6% | 564,900 |
| 2023/06/27 | 1,275 | 1,277 | 1,232.5 | 1,255.5 | -1.5 | -0.1% | 668,700 |
| 2023/06/26 | 1,266.5 | 1,269.5 | 1,240.5 | 1,257 | -9.5 | -0.8% | 445,500 |
| 2023/06/23 | 1,304 | 1,310.5 | 1,260 | 1,266.5 | -20 | -1.6% | 570,200 |
| 2023/06/22 | 1,305 | 1,318 | 1,285.5 | 1,286.5 | -27.5 | -2.1% | 567,100 |
| 2023/06/21 | 1,348 | 1,351.5 | 1,313.5 | 1,314 | -42.5 | -3.1% | 520,500 |
| 2023/06/20 | 1,365.5 | 1,369 | 1,338.5 | 1,356.5 | -18.5 | -1.3% | 313,500 |
| 2023/06/19 | 1,361 | 1,405.5 | 1,361 | 1,375 | +28 | +2.1% | 445,000 |
| 2023/06/16 | 1,339.5 | 1,374.5 | 1,333 | 1,347 | +28 | +2.1% | 671,100 |
| 2023/06/15 | 1,370 | 1,376 | 1,319 | 1,319 | -59 | -4.3% | 387,700 |
| 2023/06/14 | 1,384 | 1,391 | 1,368.5 | 1,378 | +7 | +0.5% | 365,800 |
| 2023/06/13 | 1,395 | 1,399 | 1,365 | 1,371 | -25 | -1.8% | 379,900 |
| 2023/06/12 | 1,385 | 1,422.5 | 1,372.5 | 1,396 | +25.5 | +1.9% | 472,300 |
| 2023/06/09 | 1,379 | 1,388 | 1,357 | 1,370.5 | +9.5 | +0.7% | 522,400 |
| 2023/06/08 | 1,384 | 1,384 | 1,350.5 | 1,361 | -17.5 | -1.3% | 557,100 |
| 2023/06/07 | 1,414 | 1,414 | 1,364 | 1,378.5 | -22 | -1.6% | 617,900 |
| 2023/06/06 | 1,400 | 1,414.5 | 1,371 | 1,400.5 | -18 | -1.3% | 542,300 |
| 2023/06/05 | 1,421 | 1,424 | 1,385.5 | 1,418.5 | +7.5 | +0.5% | 430,200 |
| 2023/06/02 | 1,362 | 1,413 | 1,346 | 1,411 | +34 | +2.5% | 523,500 |
| 2023/06/01 | 1,353 | 1,397 | 1,339 | 1,377 | +40 | +3% | 485,400 |
| 2023/05/31 | 1,358 | 1,364 | 1,328 | 1,337 | -51 | -3.7% | 753,500 |
| 2023/05/30 | 1,377 | 1,406 | 1,354 | 1,388 | +11 | +0.8% | 295,600 |
| 2023/05/29 | 1,370 | 1,419 | 1,335 | 1,377 | +26 | +1.9% | 604,200 |
| 2023/05/26 | 1,405 | 1,406 | 1,344 | 1,351 | -72 | -5.1% | 619,300 |
| 2023/05/25 | 1,441 | 1,455 | 1,412 | 1,423 | -29 | -2% | 514,200 |
| 2023/05/24 | 1,463 | 1,480 | 1,446 | 1,452 | -27 | -1.8% | 665,300 |
| 2023/05/23 | 1,410 | 1,518 | 1,409 | 1,479 | +102 | +7.4% | 1,584,300 |
| 2023/05/22 | 1,369 | 1,381 | 1,331 | 1,377 | -7 | -0.5% | 1,003,500 |
| 2023/05/19 | 1,301 | 1,405 | 1,301 | 1,384 | +149 | +12.1% | 2,552,000 |
| 2023/05/18 | 1,174 | 1,243 | 1,169 | 1,235 | +109 | +9.7% | 1,204,900 |
| 2023/05/17 | 1,135 | 1,155 | 1,108 | 1,126 | -1 | -0.1% | 637,500 |
| 2023/05/16 | 1,166 | 1,166 | 1,119 | 1,127 | -23 | -2% | 978,100 |
| 2023/05/15 | 1,194 | 1,199 | 1,133 | 1,150 | -43 | -3.6% | 1,242,500 |
| 2023/05/12 | 1,319 | 1,322 | 1,182 | 1,193 | -237 | -16.6% | 1,677,500 |
201～
250
件表示中 / 6711件
類似銘柄と比較する
現在ご覧いただいている「ＪＣＲファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＪＣＲファーマ | 62,200円 | -3.7% | -36.7% | 3.22% | 20.98倍 | 1.40倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ゼリア新薬 | 200,900円 | +9.6% | +17.5% | 2.29% | 11.35倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 栄研化 | 214,700円 | +7.6% | +57.5% | 2.47% | 16.58倍 | 1.63倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割弱。尿検査（ウロ）、遺伝子検査も育成 |
| あすかＨＤ | 227,700円 | +0.3% | +2.7% | 2.20% | 12.90倍 | 1.04倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| 生化学 | 78,400円 | +10.5% | +169.1% | 3.83% | 12.40倍 | 0.59倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
市場注目の銘柄
チャート関連のコラム
